Clinical Trials Browser

Terminated × INDUSTRY × surufatinib × Clear all

Neuroendocrine Tumors

NCT04579757 2025-05-08

Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors

EndocrineGastrointestinalHead & NeckNETSarcomaThoracic

Neoplasm Metastasis, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Neuroendocrine Tumors, Small Cell Lung Carcinoma, Thyroid Carcinoma, Anaplastic

NCT04427774 2021-07-20

A Study of Surufatinib Plus Sintilimab in Patients With Advanced Solid Tumor

Phase 1 Terminated

8 enrolled

Other solid neoplasm

Advanced or Metastatic Solid Tumors

Clinical Trials

Open-Label Surufatinib in European Patients With NET

Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors

A Study of Surufatinib Plus Sintilimab in Patients With Advanced Solid Tumor